Cleared Traditional

K801854 - SPINAL FLUID CONTROL(HUMAN)

K801854 is the FDA 510(k) clearance for SPINAL FLUID CONTROL(HUMAN) by Environmental Chemical Specialties. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 43-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1980
Decision
43d
Days
Class 1
Risk

K801854 is an FDA 510(k) clearance for the SPINAL FLUID CONTROL(HUMAN). Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Environmental Chemical Specialties (Mchenry, US). The FDA issued a Cleared decision on September 16, 1980 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Environmental Chemical Specialties devices

Submission Details

510(k) Number K801854 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1980
Decision Date September 16, 1980
Days to Decision 43 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 88d · This submission: 43d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 376
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K801854.
URINE PREGNANCY TEST STANDARD/CONTR. PK
K811150 · Mallinckrodt Critical Care · May 1981
HDL-CHOLESTEROL CONTROL SERUM
K802997 · Isolab, Inc. · Dec 1980
ULTIMATE DIRECT & TOTAL BILIRUBIN CONTRO
K802068 · Beckman Instruments, Inc. · Oct 1980
CODE QAS.105 PROLACTIN CONTROL SERA
K800708 · Amersham Corp. · Apr 1980
PENTEX LIPOPROTEIN CHOLESTEROL SOLU.
K800035 · Miles Laboratories, Inc. · Jan 1980
CK-MB (CREATINE KINASE-MB) RIA CONTROL
K792524 · Mallinckrodt Critical Care · Jan 1980